Physician profile
Fernando J Ocon
NPI 1053369512
$19,051.95
in general payments reported to CMS, 2019-2025
35 companies · $419 in 2025
The $419 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $358 · 2021: $9,385 · 2022: $6,763 · 2023: $945 · 2024: $709 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,072.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,028.40 | 2021-2022 | |
| Abbvie INC. | $689.80 | 2019-2024 | |
| Astellas Pharma US INC | $584.22 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $373.36 | 2021-2025 | |
| Hologic Sales and Service, LLC | $334.30 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $299.86 | 2019-2025 | |
| Exeltis, USA INC. | $223.54 | 2020-2025 | Slynd |
| Organon LLC | $151.96 | 2021-2025 | Nexplanon |
| Novo Nordisk INC | $137.95 | 2024 | Wegovy |
| Shield Therapeutics INC | $118.83 | 2022-2025 | Accrufer |
| Minerva Surgical, INC | $117.07 | 2019 | |
| Myovant Sciences INC. | $106.25 | 2021-2022 | |
| Exact Sciences Corporation | $91.30 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $90.63 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $77.21 | 2020-2025 | Gardasil 9, Gardasil |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $71.60 | 2020-2023 | Wallach Cryosurgical Equipment |
| Agile Therapeutics, INC. | $60.54 | 2021-2023 | Twirla |
| Baxter Healthcare | $50.71 | 2024 | Tisseel |
| Biogen, INC. | $46.07 | 2025 | Zurzuvae |
| Ethicon US, LLC | $44.01 | 2019-2025 | Surgicel Nu-Knit |
| Millicent US INC | $37.20 | 2025 | Femlyv, Femring, Intrarosa |
| Mylan Pharmaceuticals INC. | $34.83 | 2020-2022 | |
| Scynexis, INC. | $34.65 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $29.27 | 2023 | Vivjoa |
| Axonics, INC. | $28.49 | 2023 | Axonics |
| Stryker Corporation | $26.44 | 2021 | |
| Optumhealth Care Solutions, LLC | $23.77 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Evofem Biosciences, INC. | $23.07 | 2021 | |
| Sumitomo Pharma America, INC. | $19.09 | 2023 | Myfembree |
| Mission Pharmacal Company | $18.68 | 2023 | |
| Medtronic, INC. | $18.51 | 2024 | Ligasure |
| Lupin INC. | $18.03 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.50 | 2022 | |
| Aspira Women'S Health INC | $13.39 | 2024 | Ova1 |
| Fujifilm Healthcare Americas Corporation | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Ocon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.